Table 5. HIV prevalence in trans feminine individuals, separated by sampling method.
| Sampling method | Number of samples | Sample size | HIV prevalence (95% CI)* |
|---|---|---|---|
| Respondent driven sampling | 33 | 12202 | 23.3 (18.0–28.4) |
| STI clinic visit | 26 | 19360 | 17.4 (12.2–22.7) |
| Convenience sampling | 14 | 3733 | 19.7 (14.8–24.5) |
| Cluster sampling | 11 | 4273 | 19.6 (14.4–24.9) |
| Hospital | 5 | 827 | 15.0 (9.8–20.4) |
| Snowball | 4 | 1203 | 11.8 (8.0–15.6) |
| Surveillance | 4 | 2339 | 9.1 (6.1–12.0) |
| NGO | 2 | 213 | 37.8 (31.5–44.2) |
| Database health plan | 1 | 3475 | 5.4 (4.6–6.1) |
| Purposive sampling | 1 | 538 | 29.9 (26.1–33.8) |
Note. For one study, the sampling method was unknown and is not included in this table.
*: Results were calculated by direct standardisation of country-year sample size instead of pooling.